{{Rsnum
|rsid=3135499
|Gene=NOD2
|Chromosome=16
|position=50732216
|Orientation=plus
|GMAF=0.3857
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
|Gene_s=NOD2
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 31.9 | 56.6 | 11.5
| HCB | 54.5 | 40.9 | 4.5
| JPT | 61.3 | 33.3 | 5.4
| YRI | 17.8 | 45.9 | 36.3
| ASW | 21.4 | 48.2 | 30.4
| CHB | 54.5 | 40.9 | 4.5
| CHD | 64.2 | 33.0 | 2.8
| GIH | 60.4 | 36.6 | 3.0
| LWK | 12.7 | 48.2 | 39.1
| MEX | 0.0 | 0.0 | 0.0
| MKK | 13.9 | 41.7 | 44.4
| TSI | 22.5 | 57.8 | 19.6
| HapMapRevision=28
}}{{PMID Auto
|PMID=20595247
|Title=Polymorphisms of innate pattern recognition receptors, response to interferon-beta and development of neutralizing antibodies in multiple sclerosis patients
}}

{{PMID Auto
|PMID=22212192
|Title=Polymorphisms of NOD2 and the risk of tuberculosis: a validation study in the Chinese population
}}

{{PMID|16600026|OA=1
}} Asthma families show transmission disequilibrium of gene variants in the vitamin D metabolism and signalling pathway.

{{PMID Auto
|PMID=23100559
|Title=Association of a NOD2 gene polymorphism and Th17 lymphocytes with presumed ocular toxoplasmosis
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}